236 related articles for article (PubMed ID: 34053584)
1. Theranostics in Brain Tumors.
Shooli H; Nemati R; Ahmadzadehfar H; Aboian M; Jafari E; Jokar N; Nabipour I; Dadgar H; Gholamrezanezhad A; Larvie M; Assadi M
PET Clin; 2021 Jul; 16(3):397-418. PubMed ID: 34053584
[TBL] [Abstract][Full Text] [Related]
2. Theranostics in Nuclear Medicine: Emerging and Re-emerging Integrated Imaging and Therapies in the Era of Precision Oncology.
Gomes Marin JF; Nunes RF; Coutinho AM; Zaniboni EC; Costa LB; Barbosa FG; Queiroz MA; Cerri GG; Buchpiguel CA
Radiographics; 2020 Oct; 40(6):1715-1740. PubMed ID: 33001789
[TBL] [Abstract][Full Text] [Related]
3. An introduction to the clinical practice of theranostics in oncology.
Turner JH
Br J Radiol; 2018 Nov; 91(1091):20180440. PubMed ID: 30179054
[TBL] [Abstract][Full Text] [Related]
4. Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine.
Langbein T; Weber WA; Eiber M
J Nucl Med; 2019 Sep; 60(Suppl 2):13S-19S. PubMed ID: 31481583
[TBL] [Abstract][Full Text] [Related]
5. Personalized & Precision Medicine in Cancer: A Theranostic Approach.
Choudhury P; Gupta M
Curr Radiopharm; 2017 Nov; 10(3):166-170. PubMed ID: 28758574
[TBL] [Abstract][Full Text] [Related]
6. Theranostics and metabolotheranostics for precision medicine in oncology.
Bhujwalla ZM; Kakkad S; Chen Z; Jin J; Hapuarachchige S; Artemov D; Penet MF
J Magn Reson; 2018 Jun; 291():141-151. PubMed ID: 29705040
[TBL] [Abstract][Full Text] [Related]
7. An Impressive Approach in Nuclear Medicine: Theranostics.
Vahidfar N; Eppard E; Farzanehfar S; Yordanova A; Fallahpoor M; Ahmadzadehfar H
PET Clin; 2021 Jul; 16(3):327-340. PubMed ID: 34053577
[TBL] [Abstract][Full Text] [Related]
8. General Concepts in Theranostics.
Nunes RF; Zuppani RMF; Coutinho AM; Barbosa FG; Sapienza MT; Marin JFG; Buchpiguel CA
PET Clin; 2021 Jul; 16(3):313-326. PubMed ID: 34053576
[TBL] [Abstract][Full Text] [Related]
9. Theranostics in Neurooncology: Heading Toward New Horizons.
Tolboom N; Verger A; Albert NL; Fraioli F; Guedj E; Traub-Weidinger T; Morbelli S; Herrmann K; Zucchetta P; Plasschaert SLA; Yakushev I; Weller M; Glas M; Preusser M; Cecchin D; Barthel H; Van Weehaeghe D
J Nucl Med; 2024 Feb; 65(2):167-173. PubMed ID: 38071569
[TBL] [Abstract][Full Text] [Related]
10. The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.
Pruis IJ; van Dongen GAMS; Veldhuijzen van Zanten SEM
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033160
[TBL] [Abstract][Full Text] [Related]
11. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
Moorthy H; Govindaraju T
ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
[TBL] [Abstract][Full Text] [Related]
12. Radiotheranostics - Precision Medicine in Nuclear Medicine and Molecular Imaging.
Duan H; Iagaru A; Aparici CM
Nanotheranostics; 2022; 6(1):103-117. PubMed ID: 34976584
[TBL] [Abstract][Full Text] [Related]
13. Theranostic approaches in nuclear medicine: current status and future prospects.
Filippi L; Chiaravalloti A; Schillaci O; Cianni R; Bagni O
Expert Rev Med Devices; 2020 Apr; 17(4):331-343. PubMed ID: 32157920
[No Abstract] [Full Text] [Related]
14. Functional gadolinium-based nanoscale systems for cancer theranostics.
Li H; Zeng Y; Zhang H; Gu Z; Gong Q; Luo K
J Control Release; 2021 Jan; 329():482-512. PubMed ID: 32898594
[TBL] [Abstract][Full Text] [Related]
15. Radioligand Theranostics in the Management of Neuroendocrine Tumors.
Harris AG; Vinik AI; OʼDorisio TM; OʼDorisio MS
Pancreas; 2020; 49(5):599-603. PubMed ID: 32433395
[No Abstract] [Full Text] [Related]
16. Brain metastasis: An insight into novel molecular targets for theranostic approaches.
Santos L; Moreira JN; Abrunhosa A; Gomes C
Crit Rev Oncol Hematol; 2024 Jun; 198():104377. PubMed ID: 38710296
[TBL] [Abstract][Full Text] [Related]
17. [Nuclear medicine diagnostics, therapy and theranostics in the context of modern oncology].
Schaefer N; Prior J
Ther Umsch; 2019 Sep; 76(4):167-172. PubMed ID: 31498036
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles for SPECT and PET Imaging: Towards Personalized Medicine and Theranostics.
Polyak A; Ross TL
Curr Med Chem; 2018; 25(34):4328-4353. PubMed ID: 28875837
[TBL] [Abstract][Full Text] [Related]
19. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments.
Farolfi A; Fendler W; Iravani A; Haberkorn U; Hicks R; Herrmann K; Walz J; Fanti S
Eur Urol Oncol; 2019 Mar; 2(2):152-162. PubMed ID: 31017091
[TBL] [Abstract][Full Text] [Related]
20. Targeted radionuclide therapy: frontiers in theranostics.
Gallivanone F; Valente M; Savi A; Canevari C; Castiglioni I
Front Biosci (Landmark Ed); 2017 Jun; 22(10):1750-1759. PubMed ID: 28410143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
